ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 64 filers reported holding ALPINE IMMUNE SCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,096,354 | +17.0% | 270,424 | +5.0% | 0.00% | 0.0% |
Q2 2023 | $2,647,347 | +76.8% | 257,524 | +32.8% | 0.00% | – |
Q1 2023 | $1,497,580 | +6.4% | 193,987 | +1.3% | 0.00% | – |
Q4 2022 | $1,408,054 | +57.1% | 191,572 | +53.9% | 0.00% | – |
Q3 2022 | $896,000 | -16.3% | 124,478 | -1.0% | 0.00% | – |
Q2 2022 | $1,071,000 | +17.4% | 125,774 | +23.7% | 0.00% | – |
Q1 2022 | $912,000 | -37.7% | 101,708 | -3.7% | 0.00% | – |
Q4 2021 | $1,463,000 | +27.9% | 105,595 | -1.5% | 0.00% | – |
Q3 2021 | $1,144,000 | +11.9% | 107,234 | -5.6% | 0.00% | – |
Q2 2021 | $1,022,000 | +384.4% | 113,579 | +470.4% | 0.00% | – |
Q1 2021 | $211,000 | -15.3% | 19,913 | +0.6% | 0.00% | – |
Q4 2020 | $249,000 | +91.5% | 19,801 | +34.4% | 0.00% | – |
Q3 2020 | $130,000 | +348.3% | 14,733 | +44.6% | 0.00% | – |
Q1 2020 | $29,000 | -25.6% | 10,188 | 0.0% | 0.00% | – |
Q4 2019 | $39,000 | -4.9% | 10,188 | -0.7% | 0.00% | – |
Q3 2019 | $41,000 | -6.8% | 10,260 | -1.0% | 0.00% | – |
Q2 2019 | $44,000 | -38.0% | 10,360 | 0.0% | 0.00% | – |
Q1 2019 | $71,000 | – | 10,360 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 3,056,420 | $22,006,000 | 19.85% |
Decheng Capital Management III (Cayman), LLC | 6,708,288 | $48,300,000 | 17.51% |
GREAT POINT PARTNERS LLC | 3,448,521 | $24,829,000 | 5.98% |
Omega Fund Management, LLC | 2,029,580 | $14,613,000 | 5.35% |
Paradigm Biocapital Advisors LP | 2,214,722 | $15,946,000 | 2.13% |
Frazier Life Sciences Management, L.P. | 2,985,757 | $21,497,000 | 1.66% |
COMMODORE CAPITAL LP | 1,325,000 | $9,540,000 | 1.53% |
Octagon Capital Advisors LP | 1,225,000 | $8,820,000 | 1.52% |
RA Capital Management | 4,356,632 | $31,368,000 | 0.67% |
TCG Crossover Management, LLC | 254,569 | $1,833,000 | 0.55% |